PeriOperative ISchemic Evaluation-2 Pilot
clinical trial
Press Enter · cited answer in seconds
0 sources
PeriOperative ISchemic Evaluation-2 Pilot
Summary
PeriOperative ISchemic Evaluation-2 Pilot is a clinical trial[1].
Key Facts
- PeriOperative ISchemic Evaluation-2 Pilot is in the country of Canada[2].
- PeriOperative ISchemic Evaluation-2 Pilot's instance of is recorded as clinical trial[3].
- PeriOperative ISchemic Evaluation-2 Pilot's start time is recorded as +2009-05-31T00:00:00Z[4].
- PeriOperative ISchemic Evaluation-2 Pilot's end time is recorded as +2009-12-31T00:00:00Z[5].
- PeriOperative ISchemic Evaluation-2 Pilot's sponsor is recorded as McMaster University[6].
- PeriOperative ISchemic Evaluation-2 Pilot's main subject is recorded as randomized controlled trial[7].
- PeriOperative ISchemic Evaluation-2 Pilot's number of participants is recorded as {'unit': '1', 'amount': '+90'}[8].
- PeriOperative ISchemic Evaluation-2 Pilot's title is recorded as PeriOperative ISchemic Evaluation-2 (POISE-2) Trial: A Pilot[9].
- PeriOperative ISchemic Evaluation-2 Pilot's short name is recorded as POISE2-pilot[10].
- PeriOperative ISchemic Evaluation-2 Pilot's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}[11].
- PeriOperative ISchemic Evaluation-2 Pilot's ClinicalTrials.gov ID is recorded as NCT00860925[12].
- PeriOperative ISchemic Evaluation-2 Pilot's research intervention is recorded as clonidine[13].
- PeriOperative ISchemic Evaluation-2 Pilot's clinical trial phase is recorded as phase IV clinical trial[14].
- PeriOperative ISchemic Evaluation-2 Pilot's research subject recruitment status is recorded as completed[15].
- PeriOperative ISchemic Evaluation-2 Pilot's study type is recorded as interventional study[16].